Blood Sample Collection in Subjects with Pulmonary Nodules or CT Suspicion of Lung Cancer Save

Date Added
April 28th, 2016
PRO Number
Pro00053740
Researcher
Nichole Tanner
Keywords
Cancer, Cancer/Lung, Lung, Pulmonary
Summary

The main objective of this study is to better understand the biomarkers of patients with abnormal CT (computed tomography) scans of the lungs. Biomarkers are biologic substances found in the blood and may be related to lung disease risk and detection. We intend to enroll volunteers with abnormal CT scans who are being evaluated by a Ralph H. Johnson VA Medical Center pulmonologist as part of their standard medical care. A single blood sample will be obtained, then stored and analyzed to better understand the biomarkers found in blood and to help develop blood-based screening or diagnostic tests. Active participation in this study will be over once a blood sample is obtained. However, we may conduct medical chart reviews of some participants for up to 27 months in order to look at their medical outcomes.

Institution
MUSC
Recruitment Contact
Lindsey Owens
(843) 792-8233
owensli@musc.edu

Prospective Registry to Evaluate Percepta Bronchial Genomic Classifier Patient Data: The PERCEPTA Registry Save

Date Added
October 1st, 2015
PRO Number
Pro00048677
Researcher
Nichole Tanner
Keywords
Cancer, Lung, Pulmonary
Summary

Percepta is a new test that analyzes the cells that line the airways of the lungs to identify patients who are at low risk for lung cancer. It helps physicians decide which patients they can safely treat by follow-up CT scans instead of having to undergo a more invasive procedure, such as surgery.

Institution
MUSC
Recruitment Contact
Katherine Taylor
843-792-2297
taylkat@musc.edu

A multi-center trial comparing standard 22-gauge and 22-gauge ProCore needles for endobronchial ultrasound Save

Date Added
January 14th, 2014
PRO Number
Pro00030500
Researcher
Nichole Tanner
Keywords
Cancer, Cancer/Lung, Lung, Pulmonary
Summary

For many patients, the treatment for advanced lung cancer is often guided by the ability to analyze tumor cells for mutations. The samples of tumor can be taken from lymph glands in the chest through a minimally invasive procedure called endobronchial ultrasound (EBUS) bronchoscopy (flexible tube with a camera, light and ultrasound that is passed into the windpipe through which biopsies can be performed). The purpose of this study is to compare two commercially available EBUS biopsy needles (standard 22-gauge needle and 22-gauge Procore bibeveled needle) to determine if one needle is better than the other at obtaining tumor cells for pathologic and mutational analyses. The study will be performed in patients with known or suspected locally advanced lung cancer during a standard of care EBUS.

Institution
MUSC
Recruitment Contact
Katherine K. Taylor
843-792-2297
taylkat@musc.edu

Change_preferences

-- OR --

Create_login